Study shows variability in Medicare coverage for transgender hormone therapies

A new study has shown substantial variability in access to guideline-recommended hormone therapies for older transgender individuals insured through Medicare. The variability in Medicare coverage and out-of-pocket costs for feminizing and masculinizing therapies are detailed in an article published in LGBT Health, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

The article entitled "Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals" was coauthored by Michael Solotke, Yale University (New Haven, CT) and colleagues from San Francisco Veterans Affairs Medical Center (CA), University of California, San Francisco School of Medicine, Veterans Affairs Connecticut Healthcare System (West Haven, CT), Yale School of Medicine, Mayo Clinic (Rochester, MN), Yale School of Public Health, and Yale-New Haven Hospital.

Medicare coverage and out-of-pocket costs can vary widely depending on the medication regimen. Access to care and to certain medications may be limited to those with adequate means. The study showed that in 2018, the proportion of Medicare plans offering unrestricted coverage ranged from 5%-75% for masculinizing therapies and from 13%-100% for feminizing therapies. Out-of-pocket costs ranged from $180-$2,176 for masculinizing therapies and from $72-$3,792 for feminizing therapies in that same year.

It is unfortunate when drug costs stand in the way of optimal treatment. To minimize this problem, prescribers should be prepared to direct low income and inadequately insured patients to assistance programs, when available, to defray costs, particularly for the gonadotropin releasing hormone agonists for which generic preparations are not yet available."

William Byne, MD, Ph.D., LGBT Health Editor-in-Chief, Columbia University Vagelos College of Physicians and Surgeons, New York, NY

Journal reference:

Solotke, M.T., et al. (2020) Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals. LGBT Health.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Hormone plays vital role in early prediction of age-related morbidity in men